Unknown

Dataset Information

0

Neutralizing monoclonal antibodies against highly pathogenic coronaviruses.


ABSTRACT: The pandemic of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 coronavirus (SARS-CoV-2) is a continuing worldwide threat to human health and social economy. Historically, SARS-CoV-2 follows SARS and MERS as the third coronavirus spreading across borders and continents, but far more dangerous with long-lasting symptomatic consequences. The current situation is strong evidence that coronaviruses will continue to be pathogens of consequence in the future, thus calling for the development of neutralizing antibody-based prophylactics and therapeutics for prevention and treatment of COVID-19 and other human coronavirus diseases. This review summarized the progresses of developing neutralizing monoclonal antibodies against infection of SARS-CoV-2, SARS-CoV, and MERS-CoV, and discussed their potential applications in prevention and treatment of COVID-19 and other human coronavirus diseases.

SUBMITTER: Xiang R 

PROVIDER: S-EPMC8716168 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7498578 | biostudies-literature
| S-EPMC4867612 | biostudies-literature
| S-EPMC8190289 | biostudies-literature
| S-EPMC7144216 | biostudies-literature
| S-EPMC3567173 | biostudies-literature
| S-EPMC7243778 | biostudies-literature
| S-EPMC104439 | biostudies-literature
| S-EPMC189045 | biostudies-literature
| S-EPMC8040518 | biostudies-literature
2017-03-31 | GSE96091 | GEO